Trial Profile
Multicenter, Prospective, Randomized Study Investigating the Efficacy and Safety of a Reduced Immunosuppressive Therapy With Tacrolimus Once Daily in Comparison to Standard Triple Immunosuppression in Senior Renal Transplant Recipients
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Sep 2023
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Mycophenolate mofetil; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms REDUCE
- 12 Sep 2023 This trial has been discontinued in Denmark, according to European Clinical Trials Database record.
- 11 Apr 2021 This trial has been discontinued in Spain, according to European Clinical Trials Database record.
- 29 Dec 2020 This trial has been discontinued in Austria, as per European Clinical Trials Database record.